赵永梅

师资介绍

姓名：赵永梅

性别：女

民族：汉族

出生年月：1987年9月

职称：讲师

学历：博士

职务：讲师

研究方向：药剂

社会学术兼职：无

基金项目：

国家自然科学青年基金，82204319，靶向肝星状细胞的“隐身”基因递送系统用于肝纤维化的治疗研究，2023/01-2025/12，30万元，主持

科研成果

代表性论文

1.        Yongmei Zhao^#, Yan Zhu^#, Kai Ding, Shanshan Li, Tianqing Liu. Biomimetic nanovesicle co‑delivery system impairs energy metabolism for cancer treatment.Journal of Nanobiotechnology 2023, 21, 229.

2.        Yongmei Zhao, Yuanlin Zheng, Yan Zhu, Kai Ding, Mengjiao Zhou, Tianqing Liu. Co-delivery of gemcitabine and Triapine by calcium carbonate nanoparticles against chemoresistant pancreatic cancer. International Journal of Pharmaceutics 2023, 636, 122844.

3.        Yongmei Zhao, Yuanlin Zheng, Yan Zhu, Hongyun Li, Hongyan Zhu, Tianqing Liu. Docetaxel-loaded M1 macrophage-derived exosomes for a safe and efficient chemoimmunotherapy of breast cancer. Journal of Nanobiotechnology 2022, 20 (1), 359.

4.        Yongmei Zhao, Qiongxia Yang, Dong Liu, Tianqing Liu, Lingyan Xing. Neurotoxicity of nanoparticles: Insight from studies in zebrafish. Ecotoxicology and Environmental Safety 2022, 242, 113896.

5.        Yongmei Zhao, Tianqing Liu, Aditya Ardana, Nicholas L. Fletcher, Zachary H. Houston, Idriss Blakey, and Kristofer J. Thurecht. Investigation of a Dual siRNA/Chemotherapy Delivery System for Breast Cancer Therapy. ACS Omega 2022, 7 (20), 17119-17127.

6.        Yongmei Zhao, Yuanlin Zheng, Yan Zhu, Yi Zhang, Hongyan Zhu,Tianqing Liu, M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer, Pharmaceutics, 2021, 13(9), 1493-1505

7.        Yongmei Zhao, Kaikai Wang, Yuanlin Zheng, Xiaobao Zeng, Yi Chieh Lim,Tianqing Liu. Co-delivery of Salinomycin and Curcumin for Cancer Stem Cell Treatment by Inhibition of Cell Proliferation, Cell Cycle Arrest, and Epithelial–Mesenchymal Transition. Frontiers in Chemistry. 2021, 8, 601649

8.        Yongmei Zhao, Nicholas L. Fletcher, Anna Gemmell, Zachary H. Houston, Christopher B. Howard, Idriss Blakey, Tianqing Liu, Kristofer J. Thurecht. Investigation of the Therapeutic Potential of a SynergisticDelivery System through Dual Controlled Release of Camptothecin–Doxorubicin. Advanced Therapeutics, 2020, 1900202.

9.        Yongmei Zhao, Zhao Wei, Lim Yi Chieh, Liu Tianqing. Salinomycin-Loaded Gold Nanoparticles for Treating Cancer Stem Cells by Ferroptosis-Induced Cell Death. Molecular Pharmaceutics, 2019, 16(6): 2532-2539.

10.    Yongmei Zhao, Chen Gang, Meng Zhengjie, Gong Guangming, Zhao Wei, Wang Kaikai, Liu Tianqing. A novel nanoparticle drug delivery system based on PEGylated hemoglobin for cancer therapy, Drug Delivery, 2019, 26(1): 717-723. 

11.    Yongmei Zhao, Nicholas L. Fletcher, Tianqing Liu, Anna C. Gemmell, Zachary H. Houston, Idriss Blakey, Kristofer J. Thurecht. In vivo therapeutic evaluation of polymeric nanomedicines: effect of different targeting peptides on therapeutic efficacy against breast cancer, Nanotheranostics, 2018.8.24, 2(4): 360-370.

12.    Yongmei Zhao, Zachary H. Houston, Joshua D. Simpson, Liyu Chen, Nicholas L. Fletcher, Adrian V. Fuchs, Idriss Blakey, Kristofer J. Thurecht. Using peptide aptamer targeted polymers as a model nanomedicine for investigating drug distribution in cancer nanotheranostics. Molecular Pharmaceutics. 2017, 14, 3539-3549.